Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischem...

Updated:Jun 17,2014
AHA Science News

Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease


  • Under-treatment and under-testing in women lead to increased complications and to higher rate of case fatalities.
  • Atherosclerotic coronary artery disease (CAD) continues to be underrecognized and underdiagnosed in women, contributing to the high mortality
  • of CAD in women. 
  • This statement provides modern evidence to assist in identifying the appropriate female candidates for diagnostic testing.


    Read the full article in Circulation
    [published online ahead of print June 16, 2014]. Circulation. doi: 10.1161/CIR.0000000000000061.

Supporting Materials

Related Science

Other Resources


Did you see these recent Commentaries?


Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)

Science News View All

Scientific Sessions



Scientific Sessions 2014
Scientific Sessions is the leading cardiovascular meeting in the country with over 17,000 professionals attending annually, and over 22,000 total attendees, as reported by the Healthcare Convention and Exhibitor’s Association. 

Chicago, IL
Nov. 15–19, 2014